Bio-Techne Corp is a biotechnology company that specializes in developing and producing high-quality biotechnology tools and reagents for the life sciences market
The company offers a wide range of products, including proteins, antibodies, assays, and diagnostic tools, which are used by researchers and clinical laboratories for various applications, such as drug development, diagnostics, and disease research. With a focus on innovation, Bio-Techne aims to provide cutting-edge solutions that enhance research capabilities and improve patient outcomes in healthcare.
Major indices rallied on Wednesday after December inflation data showed underlying price pressures slowing, reducing fears of a prolonged pause in interest rate cuts by the Federal Reserve.
October inflation data meets expectations with a slight uptick in annual rate, core inflation steady at 3.3%. Fed may cut rates in Dec. Market reacts positively.
These 10 stocks had the biggest drop last week, with McKesson Corporation, BIO-TECHNE Corp, and Warner Bros. Discovery, Inc. being the worst performers.
Wall Street has regained momentum in recent sessions, with the S&P 500 Index logging the fourth consecutive gain. The benchmark reclaimed the 5,200 level in the latest trading session before ending below the level.
By the end of today, February 26, 2024, Bio-Techne (NASDAQTECH) is set to deliver a dividend payout of $0.08 per share, equating to an annualized dividend yield of 0.46%.
